Crucial Challenges of Using Waitlist Controls When Performing Empirical Research on AI and Mental Health

Researchers are increasingly studying AI’s impact on mental health, but many rely on waitlist control groups.

The article argues that this design can create scientific and ethical limits, making findings harder to interpret.

As people turn to generative AI for advice and support, weak methods could distort conclusions about safety and effectiveness.

Better clinical trial design is needed to protect research quality, product decisions, and public trust.